Akhil Paul is an experienced investor and advisor with a diverse portfolio across various industries, currently serving as an investor at Startups since September 2018 and holding multiple advisory roles including at Redesign Health, LocoNav, Knowde, Ellipsis Health, and previously at Osmosis.org and Oxford VR. Paul has also been involved in management at the Caparo Group, a multinational family-owned corporation, since 2011. Additionally, Paul has held the position of director at Christopher's since 2017 and started their career as a trading analyst at Vitol Group from 2010 to 2011. Akhil Paul holds a Bachelor's and Master's degree in Molecular and Cellular Biochemistry from the University of Oxford.
Links